Table of Contents
NEW YORK — CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months, according to published reports. Details of the strategic shift were announced in a CVS corporate memo dated Oct. 8. The company on Oct. 8 stopped taking new patients seeking antibiotics, drugs supporting muscular health, and intravenous nutrition services.
CVS bought Coram, a drug infusion services provider, for $2.1 billion in 2013."Providers of infused medications have continued to face a challenging environment for their most highly specialized, complex services, and Coram has not been immune to these challenges," the company said.
CVS said it will continue to provide specialty medications and enteral nutrition, or tube feeding, at pharmacies in Minnesota, Pennsylvania and San Diego, and provide nursing services nationwide.
